Quarterly Result5 Nov 2025, 07:22 pm
Dishman Carbogen Amcis Ltd Announces Q2 & H1FY26 Results: Net Revenue at Rs. 13,607 million
AI Summary
Dishman Carbogen Amcis Ltd, a fully integrated CDMO company, has announced their Q2 & H1FY26 results. The company's consolidated H1 FY26 net revenue stands at Rs. 13,607 million. The CDMO revenue marginally declined by 1.1% YoY in H1FY26, primarily due to lower commercial supplies. However, the CDMO revenue for Q2 FY26 is lower by 28.4% compared to Q2 FY25 due to higher revenue from CDMO business in Q2 FY25. The MM revenue increased by 85.6% QoQ and 33.7% YoY in H1FY26. The EBITDA margin stands at 21.3% in H1FY26 compared to 13.4% in H1FY25. The net debt excluding lease liabilities was CHF 141.43 mn as on September 30, 2025.
Key Highlights
- Higher Revenue from CDMO business in Q2 2024-25 is due to postponement of one of the commercial batch shipment on customer's request and re-scheduling of some of the development projects from Q1 to Q2.
- Net Revenue at Rs 13,607.0 mn in H1FY26 up by 3.65% YoY mainly due to higher Development revenue and higher Cholesterol and Vitamin D analogues revenue.
- CDMO revenue marginally declined by 1.1% YoY in H1FY26 primarily due to lower commercial supplies.
- CDMO revenue for Q2 FY26 is lower by 28.4% compared to Q2 FY25 mainly because of higher revenue from CDMO business in Q2 FY25.
- MM revenue increased by 85.6% QoQ and 33.7% YoY in H1FY26 primarily due to increase in cholesterol and Vitamin D analogues supplies.
- EBITDA Margin at 21.3% in H1FY26 compared to 13.4% in H1FY25 mainly due to increase in margins in CDMO segment from 19.0% to 25.3% QoQ and 14.0% to 21.3% YOY.
- Net Debt excluding lease liabilities was CHF 141.43 mn as on September 30, 2025 as compared to CHF 157.6 mn as on March 31, 2025.